|Assessment Process Complete
|Is indicated as for monotherapy treatment for patients diagnosed with unresectable metastatic melanoma. Rapid Review
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended
|Full submission received from Applicant
|NCPE assessment completed
|NCPE assessment outcome
|Reimbursement not recommended at the submitted price.
The HSE has approved reimbursement following confidential price negotiations October 2017.